...
机译:供体来源的改良免疫细胞输注在肾移植中的I期试验
Heidelberg Univ Hosp,Heidelberg Univ Hosp, Transplantat Immunol, Inst Immunol, Heidelberg, Germany;
Heidelberg Univ Hosp,Heidelberg Univ Hosp, Dept Nephrol, Neuenheimer Feld 162, D-69120 Heidelberg;
TolerogenixX GmbH,TolerogenixX GmbH, Heidelberg, GermanyHeidelberg Univ Hosp,Heidelberg Univ Hosp, Dept Hematol Oncol & Rheumatol, Heidelberg, GermanyHeidelberg Univ Hosp,Heidelberg Univ Hosp, Dept Clin Pharmacol & Pharmacoepidemiol, HeidelbergHeidelberg Univ Hosp,Heidelberg Univ Hosp, Dept Gastroenterol, Heidelberg, GermanyHeidelberg Univ Hosp,Heidelberg Univ Hosp, Dept Gen Visceral & Transplantat Surg, HeidelbergHeidelberg Univ Hosp,Heidelberg Univ Hosp, Inst Med Biometry & Informat, Heidelberg, GermanyHeidelberg Univ Hosp,Heidelberg Univ Hosp, Inst Pathol, Heidelberg, GermanyHeidelberg Univ Hosp,Heidelberg Univ Hosp, Ctr Infect Dis, Virol, Heidelberg, GermanyDKFZ,DKFZ, Div Funct Genome Anal, Heidelberg, GermanyRush Univ,Rush Univ, Rush Med Coll, Dept Med, Chicago, IL 60612 USA;
BLOOD-CELLS; ALLOGRAFT SURVIVAL; B-CELLS; TOLERANCE; REJECTION; CHIMERISM; GRAFT;
机译:Preemptive donor-derived anti-CD19 CAR T-cell infusion showed a promising anti-leukemia effect against relapse in MRD-positive B-ALL after allogeneic hematopoietic stem cell transplantation
机译:Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial
机译:Infusion of third-party mesenchymal stromal cells after kidney transplantation: a phase I-II, open-label, clinical study
机译:hu O雪J IE读hu AYU recipe ameliorates me桑IA类cell py R opt OSI sin contralateral kidney of UU or ATS
机译:Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. a phase II trial of the piemonte Oncology Network